Denmark prolongs suspension of AstraZeneca Covid-19 vaccine

The decision to extend suspension of AstraZeneca “was made on the basis of presumed side effects,” Tanja Erichsen of the Danish Medicines Agency said during a news conference.

Danish officials decided on Thursday to continue their suspension of the AstraZeneca Covid-19 vaccine for three more weeks while they continue evaluating the vaccine's potential link with blood clots. The decision “was made on the basis of presumed side effects,” Tanja Erichsen of the Danish Medicines Agency said during a news conference. Denmark paused the use of the AstraZeneca vaccine as a precautionary measure on March 11 after reports that a 60-year-old woman died with blood clots in several parts of her body a week after she received the vaccine, according to health officials.